Sex‐Cord Stromal Tumors in Children and Teenagers: Results of the TGM‐95 Study. Issue 12 (23rd July 2015)
- Record Type:
- Journal Article
- Title:
- Sex‐Cord Stromal Tumors in Children and Teenagers: Results of the TGM‐95 Study. Issue 12 (23rd July 2015)
- Main Title:
- Sex‐Cord Stromal Tumors in Children and Teenagers: Results of the TGM‐95 Study
- Authors:
- Fresneau, Brice
Orbach, Daniel
Faure‐Conter, Cécile
Verité, Cécile
Castex, Marie Pierre
Kalfa, Nicolas
Martelli, Hélène
Patte, Catherine - Abstract:
- <abstract abstract-type="main" xml:lang="en"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="pbc25614-sec-0001" sec-type="section"> <title>Background</title> <p>We present the results of the TGM‐95 study for gonadal sex‐cord stromal tumors (SCT).</p> </sec> <sec id="pbc25614-sec-0002" sec-type="section"> <title>Methods</title> <p>Between 1995 and 2005, children (&lt;18 years) with gonadal SCT were prospectively registered. Primary gonadal resection was recommended whenever feasible. Patients with disseminated disease or an incomplete resection received neoadjuvant or adjuvant VIP chemotherapy (etoposide, ifosfamide, cisplatinum).</p> </sec> <sec id="pbc25614-sec-0003" sec-type="section"> <title>Results</title> <p>Thirty‐eight children with ovarian SCT were registered. Median age was 10.7y. Endocrine symptoms were present in 21 cases. The histological diagnoses were as follows: juvenile (23) and adult (3) granulosa cell tumors, Sertoli‐Leydig cell tumors (11), and mixed germ cell SCT (1). An initial oophorectomy ± salpingectomy led to complete resection in 23 patients who did not receive adjuvant treatment; two of them relapsed: one achieved second complete remission whereas the other one died of disease. Fifteen patients had tumor rupture and/or malignant ascites: 11 received chemotherapy and did not relapse, four did not receive chemotherapy and relapsed with a fatal outcome in two cases. With a median follow‐up of 5.9y, the 5‐y EFS and OS rates were<abstract abstract-type="main" xml:lang="en"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="pbc25614-sec-0001" sec-type="section"> <title>Background</title> <p>We present the results of the TGM‐95 study for gonadal sex‐cord stromal tumors (SCT).</p> </sec> <sec id="pbc25614-sec-0002" sec-type="section"> <title>Methods</title> <p>Between 1995 and 2005, children (&lt;18 years) with gonadal SCT were prospectively registered. Primary gonadal resection was recommended whenever feasible. Patients with disseminated disease or an incomplete resection received neoadjuvant or adjuvant VIP chemotherapy (etoposide, ifosfamide, cisplatinum).</p> </sec> <sec id="pbc25614-sec-0003" sec-type="section"> <title>Results</title> <p>Thirty‐eight children with ovarian SCT were registered. Median age was 10.7y. Endocrine symptoms were present in 21 cases. The histological diagnoses were as follows: juvenile (23) and adult (3) granulosa cell tumors, Sertoli‐Leydig cell tumors (11), and mixed germ cell SCT (1). An initial oophorectomy ± salpingectomy led to complete resection in 23 patients who did not receive adjuvant treatment; two of them relapsed: one achieved second complete remission whereas the other one died of disease. Fifteen patients had tumor rupture and/or malignant ascites: 11 received chemotherapy and did not relapse, four did not receive chemotherapy and relapsed with a fatal outcome in two cases. With a median follow‐up of 5.9y, the 5‐y EFS and OS rates were respectively 85% and 94%. Eleven patients had localized testicular tumors (median age 0.83y): juvenile granulosa cell tumors (4), Sertoli or Leydig cell tumors (5) and not otherwise specified SCT (2). Treatment was surgery alone with an inguinal orchiectomy. None have relapsed (median follow‐up: 5.4y).</p> </sec> <sec id="pbc25614-sec-0004" sec-type="section"> <title>Conclusions</title> <p>Childhood SCT carry favorable prognosis. In ovarian SCT, surgery should be complete and non‐mutilating. Adjuvant chemotherapy efficiently prevents recurrences in cases of tumor rupture. In childhood testicular SCT, the prognosis is excellent with an inguinal orchiectomy, prompting the debate on testis‐sparing surgery. Pediatr Blood Cancer © 2015 Wiley Periodicals, Inc.</p> </sec> </abstract> … (more)
- Is Part Of:
- Pediatric blood & cancer. Volume 62:Issue 12(2015:Dec.)
- Journal:
- Pediatric blood & cancer
- Issue:
- Volume 62:Issue 12(2015:Dec.)
- Issue Display:
- Volume 62, Issue 12 (2015)
- Year:
- 2015
- Volume:
- 62
- Issue:
- 12
- Issue Sort Value:
- 2015-0062-0012-0000
- Page Start:
- 2114
- Page End:
- 2119
- Publication Date:
- 2015-07-23
- Subjects:
- Tumors in children -- Periodicals
Blood -- Diseases -- Periodicals
Cancer in children -- Periodicals
618.92 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1545-5017 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/pbc.25614 ↗
- Languages:
- English
- ISSNs:
- 1545-5009
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6417.533500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3996.xml